Breast Cancer

Women with DCIS have 4 times cancer risk

11/03/2010 | Women diagnosed with ductal carcinoma in situ are about four times as likely to develop a subsequent invasive breast cancer as undiagnosed women of a similar age, Australian data shows.


Breast care nurses in high demand

25/02/2010 | Rural practices have limited access to breast care nurses but overall access is sufficient, an Australian study reports.


Aspirin may reduce breast cancer recurrence, death

17/02/2010 | Aspirin may substantially reduce breast cancer survivors' risk of metastasis and death, researchers report.


Accelerated hypofractionated radiation therapy backed in breast cancer

17/02/2010 | Long-term follow-up of more than 1200 Canadian women has shown that accelerated, hypofractionated whole-breast irradiation is not inferior to a standard radiotherapy regimen after breast-conserving therapy for invasive breast cancer.


Avoid paroxetine tamoxifen combination

12/02/2010 | The choice of antidepressant can significantly affect survival in women taking tamoxifen for breast cancer, researchers conclude.


Evidence strengthened for hypofractionated regimens

12/02/2010 | Women with early-stage breast cancer who received hypofractionated radiotherapy regimens had fewer adverse effects than women given the international standard regimen of 50 Gy in 25 fractions, five-year results from the START trials show.


Pre-op breast MRI far from perfect

12/02/2010 | A recent study that found MRI imaging did not reduce repeat operation rates in women with breast cancer does not mean pre-operative breast MRIs should be entirely disregarded, an Australian radiologist says.


Online tool predicts cancer risk

05/02/2010 | A new online tool that estimates a woman’s risk of ovarian and breast cancer is now available to Australian healthcare professionals.


Acupuncture effective in AI joint pain

29/01/2010 | Acupuncture is a promising treatment for women with breast cancer experiencing aromatase inhibitor induced joint pain, a small study finds.


Neoadjuvant Herceptin recommended for locally advanced breast cancer

29/01/2010 | Adding neoadjuvant trastuzumab to chemotherapy should be considered in women with HER2-positive locally advanced breast cancer, the European NOAH trial has concluded.


More Breast Cancer news

Journals

Members of Oncology Update can access the following journals for free:

Most viewed articles this week

Recent comments

Related sites